DNA X, Inc. (SONM) Form 8-K — May 27, 2026

$SONMForm 8-KItems 1.01, 2.03, 3.01, 3.02, 9.01Filed May 27, 2026, 4:35 PM ET0001493152-26-025433Original filing

DNA X, Inc. (SONM) received a delisting determination from Nasdaq on May 22, 2026, due to failure to maintain the required $2.5 million in stockholders' equity, having reported a deficit of $983,000 in its Q1 2026 results. Trading of the company's common stock is scheduled to be suspended on June 2, 2026, unless the company successfully appeals the decision before a Nasdaq Hearing Panel, a process the company intends to initiate to stay the suspension. Concurrently, the company closed a securities purchase agreement with DNA Holdings Venture, Inc.

Key figures

Cash Position: 1800000
Interest Rate: 10
Maturity Date: 2026-12-31
Offering Price: 6
Bridge note surrendered: 1200000
Nasdaq equity requirement: 2500000

Price after filing

1 day: +4.2%7 days: +20.1%30 days: +16.0%

Close on the filing date to close N calendar days later (from $4.07). Historical, not a forecast.

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.